In conclusion, these results suggest that PZH relieves the immunosuppression of CD8+ T cells by suppressing PD-L1 expression in tumor cells, which may be one of the mechanisms for the antitumor effect of PZH. The gene discussed is CD8A; the disease is neoplasm.